Urea Cycle Disorders Ucd clinical trials

Explore recruiting urea cycle disorders ucd clinical trials.

Recruiting urea cycle disorders ucd studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Urea Cycle Disorders Ucd trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Double-blind, Placebo-controlled, Single and Multiple Ascending Dose Phase 1 Study of CMP-CPS-001 in Healthy Volunteers and Participants with Abnormal Heterozygous Ornithine Transcarbamylase (OTC) Genotype

Netherlands

Human Pharmacology (Phase I)- First administration to humans EU CTIS Study details

HepaStem Long-Term Safety Registry – Registry for Patients who have been administered HepaStem

Spain, Belgium, France, Bulgaria, Poland

Therapeutic exploratory (Phase II) EU CTIS Study details

Urea Cycle Disorders Ucd trials by city

Urea Cycle Disorders Ucd in Toronto Urea Cycle Disorders Ucd in Vancouver Urea Cycle Disorders Ucd in Montreal Urea Cycle Disorders Ucd in Calgary Urea Cycle Disorders Ucd in Edmonton Urea Cycle Disorders Ucd in Ottawa Urea Cycle Disorders Ucd in Winnipeg Urea Cycle Disorders Ucd in Quebec City Urea Cycle Disorders Ucd in Hamilton Urea Cycle Disorders Ucd in Kitchener Urea Cycle Disorders Ucd in London Urea Cycle Disorders Ucd in Halifax Urea Cycle Disorders Ucd in New York Urea Cycle Disorders Ucd in Los Angeles Urea Cycle Disorders Ucd in Chicago Urea Cycle Disorders Ucd in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease